Diet-induced hyperhomocysteinemia exacerbates vascular reverse remodeling of balloon-injured arteries in rat

Chinese Medical Journal

Volumn 121, Issue 22, 2008, Pages 2265-2271

  Guo, Yan Hong ^a   Chen, Feng Ying ^a   Wang, Gui Song ^a   Chen, Li ^a   Gao, Wei ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Adventitia; Arteries; Collagen; Homocysteine; Matrix metalloproteinase

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; GELATINASE A; HOMOCYSTEINE; METHIONINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; BLOOD LEVEL; BLOOD VESSEL WALL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FIBROBLAST CULTURE; HYPERHOMOCYSTEINEMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; UPREGULATION; ZYMOGRAPHY;

EID: 62749109062     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200811020-00011     Document Type: Article

References (25)

1. Maeng M, Olesen PG, Emmertsen NC, Thorwest M, Nielsen TT, Kristensen BO, et al. Time course of vascular remodeling, formation of neointima and formation of neoadventitia after angioplasty in a porcine model. Coron Artery Dis 2001; 12: 285-293.
2. Courtman DW, Franco CD, Meng Q, Bendeck MP. Inward remodeling of the rabbit aorta is blocked by the matrix metalloproteinase inhibitor doxycycline. J Vasc Res 2004; 41: 157-165.
3. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002; 90: 251-262.
4. Wald DS, Wald NJ, Morris JK, Law M. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ 2006; 333: 1114-1117.
5. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1990; 1: 228-237.
6. Zhang C, Cai Y, Adachi MT, Oshiro S, Aso T, Kaufman RJ, et al. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem 2001; 276: 35867-35874.
7. Chen C, Halkos ME, Surowiec SM, Conklin BS, Lin PH, Lumsden AB. Effects of homocysteine on smooth muscle cell proliferation in both cell culture and artery perfusion culture models. J Surg Res 2000; 88: 26-33.
8. Morita H, Kurihara H, Yoshida S, Saito Y, Shindo T, Oh-Hashi Y, et al. Diet-induced hyperhomocysteinemia exacerbates neointima formation in rat carotid arteries after balloon injury. Circulation 2001; 103: 133-139.
9. Chen KH, Guo XM, Ma DL, Guo YH, Li Q, Yang DM, et al. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Bio 2004; 6: 872-883.
10. Gu M, Brecher P. Nitric oxide-induced increase in p21 (Sdi1/Cip1/Waf1) expression during the cell cycle in aortic adventitial fibroblasts. Arterioscler Thromb Vasc Biol 2000; 20: 27-34.
11. Guo YH, Gao W, Li Q, Li PF, Yao PY, Chen K. Tissue inhibitor of metalloproteinases-4 suppresses vascular smooth muscle cell migration and induces cell apoptosis. Life Sci 2004; 75: 2483-2493.
12. Rossi GP, Maiolino G, Seccia TM, Burlina A, Zavattiero S, Cesari M, et al. Hyperhomocysteinemia predicts total and cardiovascular mortality in high risk women. J Hypertens 2006; 24: 851-859.
13. Nevado JB Jr, Imasa MS. Homocysteine predicts adverse clinical outcomes in unstable angina and non-ST elevation myocardial infarction: implications from the folate intervention in non-ST elevation myocardial infarction and unstable angina study. Coron Artery Dis 2008; 19:153-161.
14. Wang G, Mao JM, Wang X, Zhang FC. Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes. Chin Med J 2004; 117: 1650-1654.
15. Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al. NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006; 354: 1578-1588.
16. Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 2006; 296: 2720-2726.
17. Tan H, Jiang X, Yang F, Li Z, Liao D, Trial J, et al. Hyperhomocysteinemia inhibits post-injury reendothelialization in mice. Cardiovasc Res 2006; 69: 253-262.
18. Labinaz M, Pels K, Hoffert C, Aggarwal S, O'Brien ER. Time course and importance of neoadventitial formation in arterial remodeling following balloon angioplasty of porcine coronary arteries. Cardiovasc Res 1999; 41: 255-266.
19. Lessner SM, Martinson DE, Galis ZS. Compensatory vascular remodeling during atherosclerotic lesion growth depends on matrix metalloproteinase-9 activity. Arterioscler Thromb Vasc Biol 2004; 24: 2123-2129.
20. Whatling C, McPheat W, Hurt-Camejo E. Matrix management: assigning different roles for MMP-2 and MMP-9 in vascular remodeling. Arterioscler Thromb Vasc Biol 2004; 24: 10-11.
21. Sierevogel MJ, Velema E, van der Meer FJ, Nijhuis MO, Smeets M, de Kleijn DP, et al. Matrix metalloproteinase inhibition reduces adventitial thickening and collagen accumulation following balloon dilation. Cardiovasc Res 2002; 55: 864-869.
22. Bescond A, Augier T, Chareyre C, Garcon D, Hornebeck W, Charpiot P. Influence of homocysteine on matrix metalloproteinase-2: activation and activity. Biochem Biophys Res Commun 1999; 263: 498-503.
23. Mjors AK, Sengupta S, Jacobsen DW, Pyeritz RE. Upregulation of smooth muscle cell collagen production by homocysteine-insight into the pathogenesis of homocysteinuria. Mol Gen Metabolism 2002; 76: 92-99.
24. Joseph J, Joseph L, Shekhawat NS, Devi S, Wang J, Melchert RB, et al. Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. Am J Physiol Heart Circ Physiol 2003; 285: H679-H686.
25. Cheema AN, Nili N, Li CW, Whittingham HA, Linde J, van Stuylen MR, et al. Effects of intravascular cryotherapy on vessel wall repair in a balloon-injured rabbit iliac artery model. Cardiovasc Res 2003; 59: 222-233.